Am. Deveney et Jl. Waddington, PHARMACOLOGICAL CHARACTERIZATION OF BEHAVIORAL-RESPONSES TO SK-AND-F-83959 IN RELATION TO D-1-LIKE DOPAMINE-RECEPTORS NOT LINKED TO ADENYLYL-CYCLASE, British Journal of Pharmacology, 116(3), 1995, pp. 2120-2126
1 Behavioural responses to the new benzazepine derivative, SK&F 83959,
a compound that both fails to stimulate adenylyl cyclase and inhibits
the stimulation of adenylyl cyclase induced by dopamine, were charact
erized in detail. 2 In rat striatal membrane preparations, radioligand
binding studies with [H-3]-SCH 23390 and [H-3]-spiperone indicated SK
&F 83959 had a high affinity and >250 fold selectivity for D-1 over D-
2 receptors. 3 Using a rapid time-sampling behavioural check list tech
nique, SK&F 83959 (0.01-1.25 mg kg(-1)) induced grooming in the manner
of all known D-1 receptor agonists, together with some vacuous chewin
g, which declined at higher doses with the emergence of directed chewi
ng and rearing as an adjunct to prominent sniffing; no stereotyped beh
aviour was evident. 4 Grooming to SK&F 83959 (0.05 mg kg(-1)) was bloc
ked by the selective D-1 receptor antagonists, SCH 23390 (0.01-1.0 mg
kg(-1)) and BW 737C (0.04-5.0 mg kg(-1)) and was attenuated by the sel
ective D-2 receptor antagonist, YM 09151-2 (0.005-0.5 mg kg(-1)); vacu
ous chewing to SK&F 83959 was not influenced by either SCH 23390 or BW
737C and was enhanced by YM 09151-2. 5 The paradoxical induction of t
ypical D-1 receptor agonist-induced grooming by SK&F 83959, an agent s
atisfying criteria for a D-1 receptor antagonist as classically define
d, together with its blockade by typical D-1 antagonists, strongly sug
gests mediation via a 'D-1-like' site that appears to respond similarl
y to agents independent of whether they exert agonist or antagonist ac
tions at the classical adenylyl cyclase-coupled D-1 receptor. This dir
ect functional evidence for a 'D-1-like' site that is not linked to ad
enylyl cyclase readily complements neurochemical data suggesting the e
xistence of a cyclase-independent 'D-1-like' receptor that may be coup
led to phosphoinositide hydrolysis.